Ms. [**Known lastname 68938**] is a 61F with pancreatic adenocarcinoma s/p Whipple [**2102**] now with metastatic recurrence to liver s/p placement of biliary stents x 2 [**2-/2107**] currently undergoing chemotherapy cycle 2 Day 17 capecitabine/oxaliplatin admitted with altered mental status.
She has had no new medications other than recently being restarted on lasix.
Otherwise, he states she developed dry cough today and has had rash/sores on lower extremitites since right after she started 2nd cycle of chemo but denies fever, chills, any recent change in lower extremity edema.
Exam was significant for confusion, asterixis, and erythema bilateral R>L LEs concerning for cellulitis.
CT head was unremarkable and CXR revealed small to mdoerate right pleural effusion.
She received Vancomycin, Azithromycin and Ceftriaxone for pulmonary vs skin/soft tissue infection, lactulose for asterixis and elevated ammonia and potassium for hypokalemia K 3.1.
Past Medical History: ONCOLOGIC HISTORY: - diagnosed with pancreatic adenocarcinoma in [**2102**], in the context of an 80 lb.
- adjuvant chemoradiation with Xeloda and standard external beam radiotherapy, completed in [**2104-1-17**] - 4 cycles of adjuvant Gemcitabine chemotherapy with the final dose on [**2104-6-25**] - [**1-25**] adnexal mass on surveillance imaging - [**3-27**] obstructive jaundice, dual biliary drains placed; she was found to have recurrent adenocarcinoma - [**2106-5-24**] TAH/BSO: adnexal mass was thought to be metastatic pancreatic ca - [**2106-7-14**] palliative chemotherapy with Gemzar three out of four weeks - dose was reduced by 25% with her third cycle, due to thrombocytopenia, but she was still unable to get the third of three doses - starting with her fourth cycle she received Gemzar on two of a three week cycle - last dose of gemcitabine given on [**2107-6-8**] - Started Xelox on [**2107-8-3**], currently C1D13  PAST MEDICAL HISTORY: - 2 metal biliary stents placed on [**2107-3-11**] - h/o asthma/rhinitis - hypertension: currently resolved, as per pt - L4-L5 fusion: fell 10 years ago and broke L4 - cholecystectomy 3 years ago - duodenal ulcer (per patient): resected as part of Whipple surgery - recurrent pancreatitis - hives (treated with benadryl prn) - h/o C. difficile   Social History: The patient lives with her brother.
Family History: Father with type I DM, several other family members with type 2 DM.
No family history of pancreatitis or pancreatic cancer.
Her mother had endometrial cancer and her father's mother had cervical cancer.
Her maternal aunt had cancer of some type.
HEENT: Sclera anicteric, MM dry, no thrush or mucositis, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Faint crackles R base and occ scant exp wheezes.
Abdomen: soft, tender periumbilically whic pateint states is old, slightly distended, bowel sounds present, no rebound tenderness or guarding, enlarged liver and spleen palpated just below costal margin Ext: 3+ pitting edema B/L ;warm, well perfused, 2+ pulses, no clubbing, cyanosis Skin: Erythematous papular rash anterior shin with left more confluent with surrounding erythem and warmth Neuro: Able to raise both arms symmetrically.
No pronator drift.
Moving lower extremitites symmetrically.
DISCHARGE PHYSICAL EXAM General: NAD, alert and oriented x 3 HEENT: Sclera anicteric, Lungs: clear to auscultation anteriorly bilaterally, limited posterior exam given pt's difficulty/pain with sitting up and turning CV: Regular rate and rhythm, no murmurs, rubs, gallops.
Abdomen: mildly distended, mild tenderness in epigastric region, no rebound tenderness or guarding, + ascites, Skin: no erythema, 1+ edema bilaterally GU: erythematous groin/buttock rash Back: no rash evident  Pertinent Results: [**2107-9-9**] 07:11PM   LACTATE-3.6* [**2107-9-9**] 07:12PM   AMMONIA-142* [**2107-9-9**] 07:15PM   PT-18.1* PTT-25.8 INR(PT)-1.6* [**2107-9-9**] 07:15PM   PLT SMR-NORMAL PLT COUNT-172 [**2107-9-9**] 07:15PM   HYPOCHROM-OCCASIONAL ANISOCYT-2+ POIKILOCY-1+ MACROCYT-1+ MICROCYT-1+ POLYCHROM-1+ PENCIL-1+ [**2107-9-9**] 07:15PM   NEUTS-62 BANDS-0 LYMPHS-23 MONOS-15* EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2107-9-9**] 07:15PM   WBC-4.2# RBC-2.93* HGB-9.1* HCT-27.1* MCV-93 MCH-31.1 MCHC-33.6 RDW-24.5* [**2107-9-9**] 07:15PM   ASA-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2107-9-9**] 07:15PM   TSH-2.6 [**2107-9-9**] 07:15PM   OSMOLAL-278 [**2107-9-9**] 07:15PM   calTIBC-168* FERRITIN-405* TRF-129* [**2107-9-9**] 07:15PM   ALBUMIN-3.0* CALCIUM-8.3* PHOSPHATE-3.1 MAGNESIUM-1.7 IRON-79 [**2107-9-9**] 07:15PM   LIPASE-14 [**2107-9-9**] 07:15PM   ALT(SGPT)-19 AST(SGOT)-48* LD(LDH)-327* ALK PHOS-129* TOT BILI-1.4 [**2107-9-9**] 07:15PM   estGFR-Using this [**2107-9-9**] 07:15PM   GLUCOSE-114* UREA N-18 CREAT-1.1 SODIUM-134 POTASSIUM-3.1* CHLORIDE-101 TOTAL CO2-21* ANION GAP-15 [**2107-9-9**] 08:40PM URINE  MUCOUS-FEW [**2107-9-9**] 08:40PM URINE  HYALINE-[**4-28**]* [**2107-9-9**] 08:40PM URINE  RBC-[**10-8**]* WBC-[**4-28**]* BACTERIA-FEW YEAST-NONE EPI-[**4-28**] [**2107-9-9**] 08:40PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-25 GLUCOSE-NEG KETONE-15 BILIRUBIN-SM UROBILNGN-NEG PH-6.5 LEUK-TR [**2107-9-9**] 08:40PM URINE  COLOR-Amber APPEAR-Clear SP [**Last Name (un) 155**]-1.022 [**2107-9-9**] 08:40PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-POS cocaine-NEG amphetmn-NEG mthdone-NEG [**2107-9-9**] 08:40PM URINE  UHOLD-HOLD [**2107-9-9**] 08:40PM URINE  HOURS-RANDOM  Brief Hospital Course: 61F with metastatic pancreatic cancer on palliative chemotherapy admitted to ICU [**9-9**] for altered mental status and tachycardia, found to have cellulitus, who developed GI bleed and oliguria during hospital course, with transfer to oncology floor [**9-13**], discharged to [**Hospital1 1501**] [**10-4**].
# Altered Mental Status: Most likely secondary to infection vs med effect.
Sources of infection include lower extremity cellulitus vs C diff as outlined below.
Her pain regimen at discharge consists of Morphine SR (MS Contin) 15 mg PO Q12H, tylenol prn pain, and oxycodone 5 mg q6 prn severe pain.
# GIB:  Pt developing maroon stools morning of [**9-10**] x1 and an episode of bloody emesis later that day.
Of note, pt with hx of diverticulosis, and hemmorhoids on prior c-scope which could be contributing cause of GI bleed.
No further episodes of GI bleeding throughout hospital course.
# Oliguria:  Patient developed oliguria prior to transfer from [**Hospital Unit Name 153**] to the floor on [**9-13**].
Likely in setting of GIB and blood loss.
Pt with poor urine output despite multiple fluid boluses and maintenance fluids.
She had low potassium levels and was switched from lasix to torsemide.
# Sinus Tachycardia: Tachycardic on admission to [**Hospital Unit Name 153**].
Likely multifactorial secondary to anxiety/pain, hypovolemia, infection with sources of infection including cellulitis and PNA.
No leukocytosis or fever.
# Rash: Patient reportedly developed sores on lower extremities after starting 2nd cycle of chemo.
RLE also appeared superinfected as it was warm and mildly TTP c/w cellulitis.
resolving on right leg and slightly worsening on left.
# LE edema: Bilateral lower extremity edema.
Continues to have LE edema upon discharge.
# Metastatic pancreatic cancer: On admission, was on cycle 2 palliative chemo capecitabine/oxaliplatin.
No further chemotherapy.
Patient intermittently complains of abdominal pain that is abated with redirection and/or tylenol.
#Ascites: likely secondary to metastatic pancreatic cancer as well as volume overload.
A diagnostic paracentesis was performed and was negative for infection and malignancy.
Further paracentesis for therapeutic benefit was not performed given prognosis and lack of respiratory or severe abdominal symptoms.
# Pleural effusion: Patient has new right pleural effusion and ?
pneumonia on CXR but no focal infiltrate and no fever or leukocytosis.
Could be secondary to metastatic disease or sympathetic effusion from abdominal processes.
Smear showed abnormal burr cells but no schistocytes.
No interventions made.
# Asthma/rhinitis: Continued fluticasone inhaled and nasal spray, albuterol inhaler prn .
Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for ANXIETY OR NAUSEA: PLEASE NOTE WE DECREASED THE FREQUENCY TO EVERY 8 HOURS INSTEAD OF 6.
Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: Two (2) PUFFS Inhalation every 4-6 hours as needed for shortness of breath or wheezing.
4. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO every eight (8) hours as needed for nausea or anxiety.
7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO twice a day as needed for constipation.
8. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: [**11-20**]  Inhalation Q4H (every 4 hours) as needed for SOB or wheezing.
Discharge Disposition: Extended Care  Facility: [**Doctor First Name 37**] House Rehab & Nursing Center - [**Location (un) 38**]  Discharge Diagnosis: Primary: Altered mental status, NOS GI Bleed, NOS ARF, likely pre-renal cellulitis, bilateral lower extremity C diff infection coagulopathy, likely nutritional  Secondary: metastatic pancreatic carcinoma asthma  Discharge Condition: Mental Status: Confused - sometimes.
You were admitted to [**Hospital1 69**] for altered mental status.
You were found to have a gastrointestinal bleed, low urine output, lower leg cellulitis, and C. diff infection.
You were given diuretics to help remove excess fluid from your body.
